Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Forced Transdifferentiation01:28

Forced Transdifferentiation

1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cisplatin-synergistic monoterpene indole alkaloids with diverse scaffolds from Rauvolfia vomitoria.

Bioorganic chemistry·2026
Same author

Diverse Monoterpene Indole Alkaloids with Unprecedented Chemical Architectures from <i>Rauvolfia vomitoria</i> and Their Potential as Cisplatin Sensitizers.

The Journal of organic chemistry·2026
Same author

N-rGO/S@porous SiC Composite with Multidimensional Hybrid Architectures for Structural Energy-Storing Applications.

Nanomaterials (Basel, Switzerland)·2026
Same author

Cytotoxic spirocyclic polyketides and γ-lactones from endophytic fungus Talaromyces purpureogenus Y21 guided by molecular networking and SMART strategies.

Phytochemistry·2026
Same author

Modified letrozole vs GnRH antagonist protocols in ovarian aging women for IVF: an open-label, multicenter, randomized controlled trial.

Nature communications·2026
Same author

Ganglioside-Mediated Neural-Acinar Crosstalk Facilitates Pancreatic Carcinogenesis via Metaplastic Niche Remodeling.

Gastroenterology·2026

Related Experiment Video

Updated: Jul 19, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

843

Senescence program and its reprogramming in pancreatic premalignancy.

Kailing Yang1, Xiaojia Li1, Keping Xie2,3,4

  • 1Center for Pancreatic Cancer Research, The South China University of Technology School of Medicine, Guangzhou, China.

Cell Death & Disease
|August 17, 2023
PubMed
Summary

Cellular senescence, a state of irreversible cell cycle arrest, plays a dual role in pancreatic ductal adenocarcinoma (PDA) development. Understanding senescence in PDA is key to developing new treatments.

More Related Videos

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

9.6K
Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture
08:16

Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture

Published on: February 11, 2019

8.7K

Related Experiment Videos

Last Updated: Jul 19, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

843
Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

9.6K
Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture
08:16

Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture

Published on: February 11, 2019

8.7K

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Tumorigenesis involves cell immortalization, while senescence causes irreversible cell proliferation arrest.
  • Pancreatic ductal adenocarcinoma (PDA) is a lethal, multi-step disease.
  • Senescence is common in pancreatic premalignancy but can promote tumorigenesis via the microenvironment.

Purpose of the Study:

  • To review the dual roles of senescence in PDA development and progression.
  • To examine signaling pathways regulating senescence in PDA.
  • To identify targets for reactivating senescence for PDA treatment.

Main Methods:

  • Literature review of senescence in pancreatic cancer.
  • Analysis of signaling effectors controlling senescence.
  • Exploration of therapeutic strategies targeting senescence.

Main Results:

  • Senescence has contradictory roles in PDA, inhibiting early stages but promoting later progression.
  • Specific signaling pathways critically regulate senescence in the context of PDA.
  • PDA progression involves evading the anti-tumorigenic effects of senescence.

Conclusions:

  • Senescence is a critical factor in PDA development and progression.
  • Targeting senescence pathways offers potential therapeutic strategies for PDA.
  • Reactivating senescence may be a viable approach for treating pancreatic cancer.